Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
10/04/2005 | US6951648 Variant of LAV viruses |
10/04/2005 | US6951575 Forming drops of mother liquor, crystallization, producing images, computer analyzing; macromolecules of protein; drug screening |
10/04/2005 | CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g |
10/04/2005 | CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like |
09/29/2005 | WO2005090977A1 C20orf23 as modifier of the igfr pathway and methods of use |
09/29/2005 | WO2005090976A1 Pdes as modifiers of the igfr pathway and methods of use |
09/29/2005 | WO2005090403A2 Method and apparatus for antibody purification |
09/29/2005 | WO2005090395A2 Methods for increasing protein polyethylene glycol (peg) conjugation |
09/29/2005 | WO2005090389A2 Isosteric transformation |
09/29/2005 | WO2005090383A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
09/29/2005 | WO2005090381A1 Set1 proteins and uses therefor |
09/29/2005 | WO2005089911A1 Materials, methods, and systems for separating and identifying proteins from mixtures |
09/29/2005 | WO2005089910A1 Multi-compartment filter and method of filtering using same |
09/29/2005 | WO2005089503A2 Cd4-igg2 formulations |
09/29/2005 | WO2005089409A2 Sensor constructs and detection methods |
09/29/2005 | WO2005051976A3 Protein and peptide ligation processes and one-step purification processes |
09/29/2005 | WO2005023205A3 Compositions and methods for yersinia pestis treatment |
09/29/2005 | WO2004073609A3 Posh associated kinases and related methods |
09/29/2005 | US20050215769 Protein purification |
09/29/2005 | US20050215766 Allergen from mugwort pollen |
09/29/2005 | US20050215687 superparamagnetic core comprising magnetite, with coating of copolymers of acrylic acid with vinyl benzyl trimethyl ammonium chloride or acrylamidopropyl trimethyl ammonium chloride attached thereto, and polyacrylic coating stabilizes colloid; protein a and protein G as targeting moieties |
09/29/2005 | US20050214900 Enzyme/tag binding and detection system |
09/29/2005 | US20050214867 Prion protein standard and method of making same |
09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
09/29/2005 | US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/29/2005 | US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/29/2005 | US20050214741 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
09/29/2005 | CA2560259A1 Methods for increasing protein polyethylene glycol (peg) conjugation |
09/29/2005 | CA2560185A1 Novel assay for the separation and quantification of hemagglutinin antigens |
09/29/2005 | CA2559719A1 Sensor constructs and detection methods |
09/29/2005 | CA2559544A1 C20orf23 as modifier of the igfr pathway and methods of use |
09/29/2005 | CA2559543A1 Pdes as modifiers of the igfr pathway and methods of use |
09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
09/29/2005 | CA2557295A1 Improved bacterial host cell for the direct expression of peptides |
09/29/2005 | CA2556917A1 Process for preparing macrocyclic compounds |
09/28/2005 | EP1579186A2 Identification of kinase inhibitors |
09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
09/28/2005 | EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance |
09/28/2005 | EP1578910A2 Nitrilases |
09/28/2005 | EP1578907A2 Secreted protein, ztnf9 |
09/28/2005 | EP1578903A2 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
09/28/2005 | EP1578785A1 Peptides that bind to the heparin binding domain of vegf and vegfr-2 |
09/28/2005 | EP1578779A2 Erythropoietin receptor binding antibodies |
09/28/2005 | EP1578778A2 Ghrelin analogs |
09/28/2005 | EP1578776A2 Products for regulating the degradation of collagen and methods for indentifying same |
09/28/2005 | EP1578774A2 Protein purification |
09/28/2005 | EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity |
09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
09/28/2005 | EP1578769A2 Peptides and the use thereof in darkening the skin |
09/28/2005 | EP1578768A2 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use |
09/28/2005 | EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor |
09/28/2005 | EP1578527A1 Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays |
09/28/2005 | EP1578372A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
09/28/2005 | EP1578352A2 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
09/28/2005 | EP1578205A2 Biomarkers for intro-aminiotic inflammation |
09/28/2005 | EP1534404A4 Use of a clathrate modifier to promote passage of proteins during nanofiltration |
09/28/2005 | EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues |
09/28/2005 | CN1675165A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
09/28/2005 | CN1674789A Protein extraction from canola oil seed meal |
09/28/2005 | CN1673378A Mammalian cell tandem affinity purification vector and method for purifying protein complex thereof |
09/28/2005 | CN1673364A A method for extracting superoxide dismutase |
09/28/2005 | CN1220773C Affinity chromatography method of separating and purifying single-component earthworm plasminogen |
09/28/2005 | CN1220703C Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
09/27/2005 | US6950754 Apparatus and method for automated protein design |
09/27/2005 | US6949341 Diagnosing genetic disorders |
09/27/2005 | CA2108104C Fibrin sealant compositions and methods for utilizing same |
09/22/2005 | WO2005088308A2 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities |
09/22/2005 | WO2005087794A1 Process for octreotide synthesis |
09/22/2005 | WO2005087791A2 Method for the extraction of intracellular proteins from a fermentation broth |
09/22/2005 | WO2005086830A2 Raman-enhancing, and non-linear optically active nano-sized optical labels and uses thereof |
09/22/2005 | WO2003065997A3 Anti-infarction molecules |
09/22/2005 | US20050209444 Methods and kits for purifying his-tagged proteins |
09/22/2005 | US20050209441 Using human serum albumin refolding ligand as tool in reanaturation of recombinant serum proteins |
09/22/2005 | US20050209440 Solid phase native chemical ligation of unprotected or N-terminal Cysteine protected peptides in aqueous solution |
09/22/2005 | US20050209275 Beta 2-adrenergic receptor agonists |
09/22/2005 | US20050209154 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
09/22/2005 | US20050209135 Etherification of an N-protected-2-carboxyl-4-hydroxypyrrolidine with a 4-halo-quinolone, amidation with a 1-amino-2-vinylcylcopropane, deprotecting the ring nitrogen, amidation with a 7-octenoic acid, ring closing metathesis with 2nd generation Hoveyda's catalyst; one pot process; Hepatitis C viricides |
09/22/2005 | US20050209129 Immobilized metal affinity chromatography using a support charged with zinc or cobalt and an imidazole binding buffer to separate from heme proteins; high throughput assays |
09/22/2005 | US20050208604 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample |
09/22/2005 | US20050208580 Novel protein and method for producing the protein |
09/22/2005 | US20050208537 Very large scale immobilized polymer synthesis |
09/22/2005 | US20050205489 Positioned upstream of system inlet, reduces presence of non specific binding species; hydrophobic, lipophilic, activated carbon, cations, anions, ligands; fumed silica, glass; fibers, beads, membranes; affinity chromatography columns, ultrafiltration systems |
09/22/2005 | US20050205427 Accurate, high speed protein separation by isoelectric focusing; a central sample reservoir surrounded by satellite reservoirs for sequential isoelectric filtration |
09/21/2005 | EP1577382A2 Detection of TSE infectivity |
09/21/2005 | EP1577319A1 Prefilter system for biological systems |
09/21/2005 | EP1576151A2 Ap1 amine oxidase variants |
09/21/2005 | EP1576129A2 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
09/21/2005 | EP1576126A2 Systems for capture and analysis of biological particles and methods using the systems |
09/21/2005 | EP1576109A2 Methods and compositions for categorizing patients |
09/21/2005 | EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
09/21/2005 | EP1575993A2 Methods for treating patients and identifying therapeutics |
09/21/2005 | EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
09/21/2005 | EP1575991A2 Peptides comprising aromatic d-amino acids and methods of use |
09/21/2005 | EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
09/21/2005 | EP1575989A2 PrP sp sc /sp -INTERACTING MOLECULES AND USES THEREOF |
09/21/2005 | EP1575986A2 Peptides and methods for cell death regulation |
09/21/2005 | EP1575602A2 Methods for treating cancer using porimin as a target |